This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Second View: Discussing Rinvoq's label expansion for patients with giant cell arteritis.
Ticker(s): ABBVWho's the expert?
Institution: St. James' Hospital
- Rheumatologist and general physician working in St. James's Hospital, a Fellow of the Royal College of Physicians of Ireland
- Currently manages 150 patients monthly with arthritis.
- Has over 100 peer-reviewed research publications. His research focuses on vasculitis, interstitial lung disease in rheumatic diseases, and on outcomes research in acute medicine.
- Has been the lead on numerous clinical committees including the Physician Assistant Introduction Programme in Blackrock Clinic and the St. James Hospital NCHD Committee, and is the current Secretary of the Irish Society for Rheumatology Private Practice Committee.
Interview GoalThis conversation will focus on the treatment landscape and potential use of Rinvoq for patients with GCA.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
